Phase 1 Study of Concurrent Sunitinib and Image-Guided Radiotherapy Followed by Maintenance Sunitinib for Patients With Oligometastases: Acute Toxicity and Preliminary Response (vol 115, pg 3571, 2009)

被引:0
|
作者
Kao, J.
Packer, S.
Vu, H. L.
Schwartz, M. E.
Sung, M. W.
Stock, R. G.
Lo, Y-C
Huang, D.
Chen, S-H
Cesaretti, J. A.
机构
关键词
D O I
10.1002/cncr.25829
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2826 / 2826
页数:1
相关论文
共 6 条
  • [1] Phase 1 Study of Concurrent Sunitinib and Image-Guided Radiotherapy Followed by Maintenance Sunitinib for Patients With Oligometastases Acute Toxicity and Preliminary Response
    Kao, Johnny
    Packer, Stuart
    Vu, Ha Linh
    Schwartz, Myron E.
    Sung, Max W.
    Stock, Richard G.
    Lo, Yeh-Chi
    Huang, Delphine
    Chen, Shu-Hsia
    Cesaretti, Jamie A.
    CANCER, 2009, 115 (15) : 3571 - 3580
  • [2] Phase I study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases
    Kao, Johnny
    Packer, Stuart
    Ozao-Choy, Junko
    Vu, Ha
    Ma, Ge
    Schwartz, Myron
    Sung, Max
    Eisenstein, Sam
    Stock, Richard
    Cesaretti, Jamie
    Chen, Shu-hsia
    CANCER RESEARCH, 2009, 69
  • [3] Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases
    Tong, Charles C. L.
    Ko, Eric C.
    Sung, Max W.
    Cesaretti, Jamie A.
    Stock, Richard G.
    Packer, Stuart H.
    Forsythe, Kevin
    Genden, Eric M.
    Schwartz, Myron
    Lau, K. H. Vincent
    Galsky, Matthew
    Ozao-Choy, Junko
    Chen, Shu-hsia
    Kao, Johnny
    PLOS ONE, 2012, 7 (06):
  • [4] Phase I study of concurrent sunitinib (SU) and image guided radiotherapy (IGRT) followed by maintenance SU for patients with oligometastases: Preliminary results
    Kao, J.
    Sung, M.
    Schwartz, M.
    Stock, R. G.
    Dumane, V.
    Huang, D.
    Lo, Y.
    Packer, S.
    Cesaretti, J. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S142 - S142
  • [5] Phase I/II trial of concurrent sunitinib (SU) and image-guided radiotherapy (IGRT) followed by maintenance systemic therapy for patients with oligometastases
    Kao, J.
    Cesaretti, J. A.
    Sung, M. W.
    Stock, R.
    Galsky, M. D.
    Packer, S.
    Chen, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [6] Phase I/II Trial of Multitargeted Tyrosine Kinase Inhibitor Sunitinib in Combination with Image-guided Radiotherapy for Patients with Oligometastases
    Kao, J.
    Kulkarni, S.
    Packer, S.
    Sung, M.
    Cesaretti, J. A.
    Chen, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S71 - S71